PHOENIX, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a clinical-stage biotechnology company advancing regenerative medicine solutions, today announced ...
PHOENIX - Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) announced Wednesday it has completed patient enrollment in its FDA-cleared ADAPT clinical trial evaluating CELZ-201 (Olastrocel) for ...
Completion of Enrollment Positions CELZ for Near-Term Data Catalysts and Accelerates Path Toward Commercialization of a Transformative, Non-Opioid Therapy for Chronic Lower Back Pain PHOENIX, Dec. 17, ...
Nigerian women are choosing modern family planning over tradition to improve their health, finances, and break the cycle of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback